System Transmission

Top Signal

100#1 JOB

Activity

2184Ripe

+943 today

System

Live1m

Terminal Asset View

stockNASDAQ

AUTL

$1.44-1.37%

Autolus Therapeutics plc

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

22Overripe

Live Analysis Active

Synchronizing Data Stream

Establishing multi-vendor link for AUTL

Pipeline Initializing...

System Progress0%

Low Latency Link

Encrypted Port

Company Mission

Autolus Therapeutics creates advanced cell therapies designed to treat cancer by modifying a patient's own immune cells to better target and destroy cancer cells. These therapies are used in clinical trials for patients with hard-to-treat cancers like leukemia and lymphoma. The company makes money through research collaborations with other biotech firms, grants, and by advancing its therapies through clinical development stages toward potential future commercialization.

AUT

Industry Context

Autolus operates in the biotechnology industry, specifically focusing on cell therapy for cancer treatment. This sector is highly research-driven, where companies develop experimental treatments through clinical trials.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

60Matrix

Market Momentum

41.4— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

-1.37%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing AUTL across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:34 AM UTC

As-of 03-15-2026 02:19 UTC

Develops cancer treatments that reprogram patients' own immune cells to fight tumors and earns money through drug sales and research partnerships.

Price has been trending lower and remains below key moving averages, suggesting continued caution among investors in the near term showing showing.

Biotech sector faces volatility as regulatory approvals and clinical trial results drive sentiment, with investors watching for breakthrough,.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...